These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 1436033)

  • 1. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
    Shull MM; Ormsby I; Kier AB; Pawlowski S; Diebold RJ; Yin M; Allen R; Sidman C; Proetzel G; Calvin D
    Nature; 1992 Oct; 359(6397):693-9. PubMed ID: 1436033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.
    Boivin GP; O'Toole BA; Orsmby IE; Diebold RJ; Eis MJ; Doetschman T; Kier AB
    Am J Pathol; 1995 Jan; 146(1):276-88. PubMed ID: 7856734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.
    Diebold RJ; Eis MJ; Yin M; Ormsby I; Boivin GP; Darrow BJ; Saffitz JE; Doetschman T
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12215-9. PubMed ID: 8618872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.
    Geiser AG; Letterio JJ; Kulkarni AB; Karlsson S; Roberts AB; Sporn MB
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9944-8. PubMed ID: 8234339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
    Kulkarni AB; Huh CG; Becker D; Geiser A; Lyght M; Flanders KC; Roberts AB; Sporn MB; Ward JM; Karlsson S
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):770-4. PubMed ID: 8421714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysregulation in TGF-beta 1-deficient mice.
    Christ M; McCartney-Francis NL; Kulkarni AB; Ward JM; Mizel DE; Mackall CL; Gress RE; Hines KL; Tian H; Karlsson S
    J Immunol; 1994 Sep; 153(5):1936-46. PubMed ID: 8051399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice.
    Luetteke NC; Qiu TH; Peiffer RL; Oliver P; Smithies O; Lee DC
    Cell; 1993 Apr; 73(2):263-78. PubMed ID: 8477445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound healing in the transforming growth factor-beta-deficient mouse.
    Brown RL; Ormsby I; Doetschman TC; Greenhalgh DG
    Wound Repair Regen; 1995; 3(1):25-36. PubMed ID: 17168860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.
    Wolf G; Mueller E; Stahl RA; Ziyadeh FN
    J Clin Invest; 1993 Sep; 92(3):1366-72. PubMed ID: 7690779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene targeting yields a CD18-mutant mouse for study of inflammation.
    Wilson RW; Ballantyne CM; Smith CW; Montgomery C; Bradley A; O'Brien WE; Beaudet AL
    J Immunol; 1993 Aug; 151(3):1571-8. PubMed ID: 8101543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta (TGF-beta) and autoimmunity.
    Aoki CA; Borchers AT; Li M; Flavell RA; Bowlus CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):450-9. PubMed ID: 16137611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Sjögren's-like lesions in salivary glands of TGF-beta1-deficient mice are inhibited by adhesion-blocking peptides.
    McCartney-Francis NL; Mizel DE; Redman RS; Frazier-Jessen M; Panek RB; Kulkarni AB; Ward JM; McCarthy JB; Wahl SM
    J Immunol; 1996 Aug; 157(3):1306-12. PubMed ID: 8757639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro.
    Suzumura A; Sawada M; Yamamoto H; Marunouchi T
    J Immunol; 1993 Aug; 151(4):2150-8. PubMed ID: 8345199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.
    Kobayashi S; Yoshida K; Ward JM; Letterio JJ; Longenecker G; Yaswen L; Mittleman B; Mozes E; Roberts AB; Karlsson S; Kulkarni AB
    J Immunol; 1999 Oct; 163(7):4013-9. PubMed ID: 10491004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The liver in transforming growth factor-Beta-1 (TGF-beta 1) null mutant mice.
    Williams AO; Knapton AD; Geiser A; Letterio JJ; Roberts AB
    Ultrastruct Pathol; 1996; 20(5):477-90. PubMed ID: 8883333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of transcription of the germ-line Ig alpha constant region gene by an ATF element and by novel transforming growth factor-beta 1-responsive elements.
    Lin YC; Stavnezer J
    J Immunol; 1992 Nov; 149(9):2914-25. PubMed ID: 1401921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
    Goldberg SR; McKinstry RP; Sykes V; Lanning DA
    J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
    Sterner-Kock A; Thorey IS; Koli K; Wempe F; Otte J; Bangsow T; Kuhlmeier K; Kirchner T; Jin S; Keski-Oja J; von Melchner H
    Genes Dev; 2002 Sep; 16(17):2264-73. PubMed ID: 12208849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 in reproduction and development.
    Shull MM; Doetschman T
    Mol Reprod Dev; 1994 Oct; 39(2):239-46. PubMed ID: 7826627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands.
    Nandula SR; Amarnath S; Molinolo A; Bandyopadhyay BC; Hall B; Goldsmith CM; Zheng C; Larsson J; Sreenath T; Chen W; Ambudkar IS; Karlsson S; Baum BJ; Kulkarni AB
    Arthritis Rheum; 2007 Jun; 56(6):1798-805. PubMed ID: 17530708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.